image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Scapa

January 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SCPA
  • Price:
  • 234p
The once high flying shares have been buffeted first by a softening of demand in the woundcare market and then by news that Convatec, 191p, had cancelled the last three years of a five year contract. However, long-standing CEO Haejae Chae has come out of retirement to assist, including filing a claim for US$83m damages in Connecticut against Convatec (Scapa has also struck out a counter claim) while there are now signs of recovery.Interim results showed the effect of Convatec with profit falling 17% to £14.2m and operating margins down from 12.2% to 8.8%. Eps fell almost 16% to 7p. In healthcare, which supplies products such as adhesive backed medical devices and silicon-based wound dressings, sales rose 23% to £71.1m. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe